Quarterly report pursuant to Section 13 or 15(d)

Net Loss Per Share (Tables)

v3.23.1
Net Loss Per Share (Tables)
3 Months Ended
Mar. 31, 2023
Earnings Per Share [Abstract]  
Schedule of Anti-Dilutive Securities that Could Potentially be Dilutive in Future

The table below represents the anti-dilutive securities that could potentially be dilutive in the future for the periods presented:

 

 

As of March 31,

 

(in shares of common stock)

 

2023

 

 

2022

 

Stock options

 

 

1,148,129

 

 

 

1,938,804

 

Restricted stock units

 

 

17,617,600

 

 

 

16,076,087

 

FP Combination Warrants

 

 

8,291,704

 

 

 

8,291,704

 

Combination Warrants

 

 

2,763,902

 

 

 

2,763,902

 

Public Warrants

 

 

19,221,960

 

 

 

11,499,960

 

Private Placement Warrants

 

 

78,000

 

 

 

7,800,000

 

2027 Warrants

 

 

17,253,279

 

 

 

 

PIPE Investment Obligation

 

 

12,228,261

 

 

 

3,270,349

 

Conversion Option Derivative

 

 

35,956,013

 

 

 

 

Schedule of Computations of Basic and Diluted Net Loss Per Share

The computations of basic and diluted net loss per share for the periods presented were as follows:

 

 

 

Three Months Ended March 31,

 

(in thousands, except per share and share amounts)

 

2023

 

 

2022

 

Numerator:

 

 

 

 

 

 

Net loss

 

$

(54,445

)

 

$

(71,372

)

Denominator:

 

 

 

 

 

 

Weighted-average shares outstanding - basic and diluted

 

 

144,062,103

 

 

 

83,643,940

 

Net loss per share - basic and diluted

 

$

(0.38

)

 

$

(0.85

)